Match Group, Inc.·4

Jun 18, 5:06 PM ET

Jones Laura Rachel 4

4 · Match Group, Inc. · Filed Jun 18, 2026

Research Summary

AI-generated summary of this filing

Updated

Match Group (MTCH) Director Laura Rachel Jones Exercises Derivatives, Receives RSUs

What Happened

  • Laura Rachel Jones, a director of Match Group (MTCH), had derivative instruments convert into 8,444 shares (8,250 + 194) on June 16, 2026 and shows corresponding dispositions reported at $0 (no cash proceeds). On the same date she received a grant of 6,845 restricted stock units (RSUs) reported at $0.
  • Reported prices/proceeds: the conversions/exercises are shown with N/A or $0 prices and $0 total proceeds, indicating these were conversions/settlements rather than open‑market sales. The RSU grant is reported at $0 (standard for equity awards).

Key Details

  • Transaction date: June 16, 2026; Form filed June 18, 2026 (timely filing).
  • Conversion/exercise: 8,250 shares and 194 shares (code M); proceeds listed as $0.
  • Grant/award: 6,845 RSUs (code A) granted, $0 reported.
  • Holdings after transactions: filing notes Ms. Jones holds 15,477 common shares plus 3,338 deferred share units under the company’s Deferred Compensation Plan (per footnote).
  • Relevant footnotes: RSUs convert one‑for‑one to common stock (F1); dividend equivalents convert to common stock (F3); certain RSUs vested as of June 16/18, 2026 (F5, F6); the new 6,845 RSUs vest later (earlier of June 16, 2027 or next Annual Meeting) subject to service (F7).

Context

  • These filings reflect equity conversions and an award, not open‑market purchases or sales. The $0 proceeds typically indicate conversion or net settlement of derivatives/RSUs rather than a cash sale. This is common when RSUs vest or dividend equivalents are converted into shares; such transactions are administrative and do not necessarily indicate a change in the director’s market view.

Insider Transaction Report

Form 4
Period: 2026-06-16
Transactions
  • Exercise/Conversion

    Common Stock, par value $0.001

    [F1][F2]
    2026-06-16+8,25018,621 total
  • Exercise/Conversion

    Common Stock, par value $0.001

    [F3][F4]
    2026-06-16+19418,815 total
  • Exercise/Conversion

    Restricted Stock Units

    [F1][F5]
    2026-06-168,2500 total
    Common Stock, par value $0.001 (8,250 underlying)
  • Exercise/Conversion

    Dividend Equivalents

    [F3][F6]
    2026-06-161940 total
    Common Stock, par value $0.001 (194 underlying)
  • Award

    Restricted Stock Units

    [F1][F7]
    2026-06-16+6,8456,845 total
    Common Stock, par value $0.001 (6,845 underlying)
Footnotes (7)
  • [F1]Restricted stock units convert into common stock on a one-for-one basis.
  • [F2]Includes (i) 15,283 shares of common stock and (ii) 3,338 share units (rounded to the nearest whole number) accrued under the 2020 Match Group, Inc. Deferred Compensation Plan for Non-Employee Directors as of the date of this report.
  • [F3]Dividend equivalents convert into common stock on a one-for-one basis.
  • [F4]Includes (i) 15,477 shares of common stock and (ii) 3,338 share units (rounded to the nearest whole number) accrued under the 2020 Match Group, Inc. Deferred Compensation Plan for Non-Employee Directors as of the date of this report.
  • [F5]Represents restricted stock units that vested on the earlier of (i) June 18, 2026 and (ii) June 16, 2026, the date of the next Annual Stockholder Meeting of Match Group, Inc. following the grant date.
  • [F6]The dividend equivalents accrued on restricted stock units that vested on the earlier of (i) June 18, 2026 and (ii) June 16, 2026, the date of the next Annual Stockholder Meeting of Match Group, Inc. following the grant date.
  • [F7]Represents restricted stock units that vest on the earlier of (i) June 16, 2027 and (ii) the date of the next Annual Stockholder Meeting of Match Group, Inc. following the grant date, subject to continued service.
Signature
David Shipley as Attorney-in-Fact for Laura Rachel Jones|2026-06-18

Documents

1 file
  • 4
    wk-form4_1781816773.xmlPrimary

    FORM 4